As described by Bernardes et al.14,15, these two sesquiterpene lactones are capable of modulating the inflammation in gout by inhibiting neutrophil migration and the release of pro-inflammatory cytokines and are capable of tempering hyperuricemia by reducing serum UA levels through an inhibition of XO activity and an increase in UA excretion. This evidence concerns the gene XDH and hyperuricemia.